Bal Pharma Ltd

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a sustained period of underperformance relative to the broader market and sector benchmarks.

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and sector-wide challenges.

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Bal Pharma has reached a new 52-week low of Rs.70.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting ongoing pressures on its financial performance and valuation metrics.

Bal Pharma's shares reached a fresh 52-week low of Rs.70.2 today, marking a significant decline amid ongoing downward momentum. The stock has recorded losses over the past two sessions, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector.

Bal Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook driven by recent financial results, valuation considerations, and technical trends. This shift highlights the complexities facing the pharmaceutical company amid ongoing sector challenges and market pressures.

Bal Pharma's shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock's ongoing downward trajectory. This new low reflects continued pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.

Bal Pharma’s shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock declined by 2.05% during the trading session, underperforming its sector peers and continuing a trend of subdued market performance over the past year.

Bal Pharma's shares reached a fresh 52-week low of Rs.73.61 today, marking a continuation of the stock's downward trajectory over recent sessions. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.

Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions.

Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector and highlights the challenges faced by the company in recent periods.

Bal Pharma has reached a new 52-week low of Rs.74.2 today, marking a significant decline amid a sustained downward trajectory over the past week. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Bal Pharma has reached a new 52-week low of Rs.75 today, marking a significant decline amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.

Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock has been on a downward trajectory for six consecutive trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock has been trading below all key moving averages and continues to underperform its sector and benchmark indices.

Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock’s recent performance contrasts sharply with broader market gains, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Bal Pharma has reached a new 52-week low of Rs.75 today, marking a significant decline amid a sustained period of negative returns. The stock has experienced a six-day consecutive fall, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Bal Pharma’s shares touched a fresh 52-week low of Rs.75 today, marking a significant decline amid a sustained downward trend. The stock has been under pressure for six consecutive sessions, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector.